Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer
Provided By GlobeNewswire
Last update: Aug 20, 2025
REDWOOD CITY, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced the appointment of Sunil Karnawat as Chief Commercial Officer, effective August 18, 2025.
Read more at globenewswire.com
